Figure 2. Correlation of IL7R^highSH2B3^low expression with clinical features in ALL.

A-B. Comparison of high risk factors [high median WBC (10⁹/L), WBC≥30×10⁹/L, PB blasts] (A) and patient age ≥35 years old (B) in patients with IL7R^highSH2B3^lowexpression to those in patients with IL7R^lowSH2B3^highexpression; C-D. Comparison of percentage of splenomegaly or enlarged lymph node (C) and co-existence of Ik6 (+) or Ph (+) chromosome (D) in these two patients' groups. E-F. Comparison of one-year relapse rate (E) and event-free survival (F) in patients with IL7R^highSH2B3^lowexpression to those in patients with IL7R^lowSH2B3^high expression.